๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Recent trends and racial/ethnic differences in the incidence and treatment of ductal carcinoma in situ of the breast in California women

โœ Scribed by Kaire Innos; Pamela L. Horn-Ross


Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
95 KB
Volume
97
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

BACKGROUND

The rapid increase in the incidence of ductal carcinoma in situ (DCIS) of the breast in the U.S. has been associated with the widespread adoption of screening mammography. Little is known regarding the incidence and treatment of DCIS in women of racial/ethnic groups other than white and black. The current investigation examined recent trends and racial/ethnic differences in the incidence and treatment of DCIS in California.

METHODS

All cases of DCIS diagnosed in women age โ‰ฅ 40 years in California between 1988โ€“1999 were included. Ageโ€adjusted incidence rates for white, black, Hispanic, and Asianโ€Pacific Islander women were calculated using the 2000 U.S. female population as the standard. The estimated annual percent change (EAPC) in the rates was calculated using least squares regression.

RESULTS

The average annual ageโ€adjusted incidence of DCIS (1988โ€“1999) was 45.3 per 100,000 in white women, 35.0 in black women, 30.9 in Asianโ€Pacific Islander women, and 21.8 in Hispanic women. Although a steady increase in the incidence of DCIS was noted in all racial/ethnic groups over the study period, Asianโ€Pacific Islander women were found to have experienced the steepest increase (EAPC = 9.1%), particularly in the age group 50โ€“64 years (EAPC = 12.0%). The DCIS incidence was reported to increase with age in white, black, and Hispanic women, but remained fairly constant after the age of 50 years in Asianโ€Pacific Islanders. The proportion of women with DCIS treated with mastectomy decreased from 53% in 1988 to 32% in 1999. Younger women and Asianโ€Pacific Islander women reportedly were more likely to undergo mastectomy.

CONCLUSIONS

Considerable differences by race/ethnicity and age were observed in DCIS incidence and the change in the incidence in California between 1988 and 1999. Further information is needed to determine whether these differences are because of differential utilization of screening mammography or biologic characteristics of DCIS lesions. Cancer 2003;97:1099โ€“106. ยฉ 2003 American Cancer Society.

DOI 10.1002/cncr.11104


๐Ÿ“œ SIMILAR VOLUMES


Ductal carcinoma in situ of the male bre
โœ Mauricio G. Camus; Megha G. Joshi; Gasan Mackarem; Arthur K. C. Lee; Ricardo L. ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 480 KB ๐Ÿ‘ 2 views

Background. Ductal carcinoma in situ (DCIS) of the male breast is an uncommon disease, accounting for approximately 7% of all male breast carcinomas. Compared with invasive carcinomas of the breast, the prognosis associated with DCIS in men is excellent; however, clinical features, pathology, and tr

Heterogeneity of ductal carcinoma in sit
โœ Michael D. Lagios ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 395 KB

Ductal carcinoma in situ (DCIS) now accounts for 20-30% of all newly diagnosed breast cancers in centers which use mammographic surveillance as a standard part of the examination. The majority of these DCIS lesions, at least in the United States, are of very limited size, with mean estimated extents

Thoughts about ductal carcinoma in situ
โœ Lawrence, Walter ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 31 KB ๐Ÿ‘ 2 views

Ductal carcinoma in situ (DCIS) was a relatively uncommon disease process when we relied on palpation to detect breast lesions. With the advent of more widespread mammography screenings, the surgeon is faced with a welcome opportunity to prevent cancer by dealing with a precursor lesion. Discovering

Aberrant expression of muc1 mucin in duc
โœ Ellen C.M. Mommers; Angelique M. Leonhart; Silvia von Mensdorff-Pouilly; Dick J. ๐Ÿ“‚ Article ๐Ÿ“… 1999 ๐Ÿ› John Wiley and Sons ๐ŸŒ French โš– 91 KB ๐Ÿ‘ 2 views

MUC1 mucin is a high molecular weight transmembrane glycoprotein expressed on the apical cell surface of normal glandular epithelia. In many human adenocarcinomas, this protein is up-regulated and/or underglycosylated, and its expression changes from apical to the entire cell membrane. It is thought